Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786004 · ClinicalTrials.gov registry record · NA
Image Quality Assessment for Screening and Diagnostic Mammography
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02786004: Completed NA study, sponsored by GE Healthcare.
NCT02786004 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02786004, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is being conducted to determine the image quality of images using a new investigational medical imaging device.
Primary Outcome
Overall clinical image quality was assessed by Mammography Quality Standards Act (MQSA) qualified radiologists ("readers"). Readers documented acceptability of FFDM and DBT image quality and image characteristics, as set for in the Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Full Field Digital Mammography System (2012).
Interventions
- DEVICE Full Field Digital Mammography
- DEVICE Digital Breast Tomosynthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT02786004 record still lists
NCT02786004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Full Field Digital Mammography is the first listed.
NCT02786004 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02786004 about?
NCT02786004 is a clinical study titled "Image Quality Assessment for Screening and Diagnostic Mammography". This study is being conducted to determine the image quality of images using a new investigational medical imaging device.
What is the current status of trial NCT02786004?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-02. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02786004?
The interventions under investigation include: Full Field Digital Mammography (DEVICE), Digital Breast Tomosynthesis (DEVICE).
Who is sponsoring clinical trial NCT02786004?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02786004's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia